Skip to main content
. 2021 Feb 5;38(3):e14509. doi: 10.1111/dme.14509

FIGURE 2.

FIGURE 2

The potential interplay of SARS‐CoV‐2 and diabetes. SARS‐CoV‐2 is characterized by a local and systemic immune response mediated by virus entry to cells via ACE2 (angiotensin converting enzyme 2) leading to multi‐organ inflammation. This response may be exacerbated by hyperglycaemia in patients with diabetes, affecting both the immune system and the inflammatory response